Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C

doi:10.4254/wjh.v9.i6.310

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7850)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

355

WORD

276

HTML

3110

Figures (1-2)

179

Tables (1-3)

184

Sum=4104

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

424

Download

823

Sum=1247

Publishing Process of This Article

Item

Count

Browse

1081

Download

1418

Sum=2499

Feb 28, 2017 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Feb 28, 2017; 9(6): 310-317
Published online Feb 28, 2017. doi: 10.4254/wjh.v9.i6.310

Table 1 Demographic, laboratory and histological features of patients with chronic hepatitis C of both populations

Variables	All (n = 760)	Rio population (n = 222)	Angers population (n = 538)
Females, n (%)	401 (54)	134 (60)	179 (35)
Age (yr, mean ± SD)	46 ± 11	51 ± 11	46 ± 11
AST, IU/L (mean ± SD)	67 ± 58	68 ± 52	66 ± 60
ALT, IU/L (mean ± SD)	101 ± 84	100 ± 67	101 ± 90
Platelet count, 10⁶/mm³ (mean ± SD)	208 ± 68	203 ± 63	210 ± 70
GGT, IU/L (mean ± SD)	144 ± 171	124 ± 135	110 ± 184
APRI	1.0 ± 1.2	0.9 ± 1.2	1.1 ± 1.3
Forns		6.0 ± 1.9
FibroMeter^Virus3G	0.6 ± 0.3	0.6 ± 0.3	0.6 ± 0.3
Biopsy length (mm, mean ± SD)	22 ± 9	24 ± 5	22 ± 10
METAVIR stage, n (%)
F0	22 (3)	5 (2)	17 (3)
F1	283 (37)	91 (41)	192 (36)
F2	215 (28)	55 (25)	160 (30)
F3	145 (19)	54 (24)	91 (17)
F4	95 (13)	17 (8)	78 (14)

AST: Aspartate transaminase; ALT: Alanine aminotransferase; GGT: Glutamyl transpeptidase; APRI: Aspartate transaminase to platelet ratio index.

Citation: Chindamo MC, Boursier J, Luiz RR, Fouchard-Hubert I, Pannain VLN, de Araújo Neto JM, Coelho HSM, de Mello Perez R, Calès P, Villela-Nogueira CA. Fibrosis assessment using FibroMeter combined to first generation tests in hepatitis C. World J Hepatol 2017; 9(6): 310-317
URL: https://www.wjgnet.com/1948-5182/full/v9/i6/310.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i6.310